Antonio Guerrero

2PUBLICATIONS
6CO-AUTHORS
Cellular immunologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 03, 2026
Immunotherapy Rechallenge in HCC: A Second Chance for Response?

|Feb 23, 2026
Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial).

Marco Sanduzzi-Zamparelli, Ana Matilla, José Luis Lledo

Pageof 1